Larson Financial Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02K Sell
193
-148
-43% -$779 ﹤0.01% 3306
2026
Q1
$1.43K Hold
341
﹤0.01% 3063
2025
Q4
$1.64K Hold
341
﹤0.01% 2821
2025
Q3
$1.73K Buy
341
+193
+130% +$853 ﹤0.01% 2762
2025
Q2
$596 Hold
148
﹤0.01% 2811
2025
Q1
$404 Hold
148
﹤0.01% 2628
2024
Q4
$629 Hold
148
﹤0.01% 2142
2024
Q3
$435 Hold
148
﹤0.01% 2161
2024
Q2
$515 Hold
148
﹤0.01% 1833
2024
Q1
$422 Hold
148
﹤0.01% 1573
2023
Q4
$522 Buy
+148
New +$425 ﹤0.01% 1571

Other funds holding SRTA

Larson Financial Group's SRTA Position: Q2 2026 in Review

Larson Financial Group reduced its Strata Critical Medical Inc (SRTA) stake by 43% in Q2 2026, selling an estimated $779 and leaving 193 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

Larson Financial Group first reported a position in SRTA in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.73K in Q3 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Larson Financial Group held 193 shares of Strata Critical Medical Inc worth $1.02K as of Q2 2026.
  • Larson Financial Group sold 148 Strata Critical Medical Inc shares in Q2 2026, an estimated $779.
  • Strata Critical Medical Inc made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3306 holding.
  • Larson Financial Group first reported a position in Strata Critical Medical Inc in Q4 2023 and has held it in 11 quarters since.
  • Larson Financial Group's Strata Critical Medical Inc position peaked at $1.73K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.